| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,744 |
8,956 |
$440K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,375 |
12,597 |
$406K |
| 20610 |
|
5,622 |
4,536 |
$187K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,838 |
1,726 |
$142K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,383 |
2,257 |
$136K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,715 |
842 |
$57K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,940 |
4,554 |
$26K |
| 73630 |
|
1,490 |
1,273 |
$25K |
| 73610 |
|
1,213 |
1,057 |
$19K |
| 99215 |
Prolong outpt/office vis |
213 |
204 |
$14K |
| 73564 |
|
666 |
502 |
$11K |
| 20526 |
|
122 |
111 |
$5K |
| 73030 |
|
366 |
321 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
241 |
217 |
$5K |
| 73560 |
|
339 |
259 |
$4K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
589 |
506 |
$3K |
| 99406 |
|
332 |
298 |
$3K |
| 99245 |
|
15 |
12 |
$2K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
13 |
13 |
$1K |
| 99253 |
|
14 |
13 |
$1K |
| 73562 |
|
76 |
51 |
$1K |
| 11721 |
|
68 |
66 |
$950.41 |
| 73140 |
|
31 |
27 |
$439.22 |
| 73502 |
|
15 |
13 |
$287.22 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
784 |
684 |
$263.90 |
| 99024 |
|
58 |
55 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
57 |
50 |
$0.00 |